Prostate cancer screenings slash the risk of dying from the disease in the following decades, according to new research. The screening measures the amount of prostate-specific antigen (PSA) in men’s ...

Cancer is a disease in which abnormal cells grow in an uncontrolled way. These cells can invade nearby tissues and, in many ...

Erleada significantly reduces the risk of death by 51% in mCSPC patients compared to Nubeqa, without chemotherapy, over 24 months. The study used inverse probability of treatment weighting to ensure ...

This may also help explain why coupled men statistically trend toward living ...